Fundraising Fox

Nadim Ahmed

President and Chief Executive Officer at Cullinan Therapeutics

Cambridge, Massachusetts, United States

Find your path to Nadim

President and Chief Executive Officer at Cullinan Therapeutics

Intro paths

→

In turn, Nadim can intro founders to Cullinan Therapeutics's investors below.

Cullinan Therapeutics's investors · 4

Biotechnology Value FundSan FranciscoForesite CapitalWest HollywoodNextech InvestZurich · $648K – $3.2M checksOrbiMedNew York · $1M – $75M checks

Experience

  1. Disc MedicineBoard Directorcurrent2025 — present
  2. Cullinan TherapeuticsPresident and CEOcurrent2021 — present
  3. Cullinan TherapeuticsPresident and CEOcurrent2021 — present
  4. Bristol Myers SquibbEVP and President, Hematology2019 — 2021
  5. Celgene CorporationPresident, Global Hematology & Oncology2017 — 2019

Skills & more

Drug Discovery1Drug DevelopmentClinical DevelopmentExecutive LeadershipThought LeadershipCross-functional Team LeadershipBusiness StrategyBiotechnologyBiotechnology IndustrySales & Marketing7Marketing7General Management9
+4 moreInternational MarketingClinical ResearchMedical AffairsManagement

From Nadim's professional profile.

Frequently asked questions

Who is Nadim Ahmed?
President and Chief Executive Officer at Cullinan Therapeutics
Where does Nadim Ahmed work?
Nadim Ahmed is President and Chief Executive Officer at Cullinan Therapeutics.

Shared employers

Also worked at Disc Medicine7

Kevin BittermanPartner at Atlas VentureEric M. SnyderPartner at Novo HoldingsSarah TullerChief Regulatory Officer at Opus GeneticsJean FranchiChief Financial Officer at Disc MedicinePamela StephensonChief Commercial Officer at Disc MedicineRahul Rajan KaushikChief Technical Officer at Disc Medicine

+ 1 more

Also worked at Cullinan Therapeutics5

Kristen LaguerreExecutive Partner at MPM BioImpactTony RosenbergManaging Director at MPM BioImpactMittie DoyleChief Medical Officer at Avalo TherapeuticsMary Kay FentonChief Financial Officer at Cullinan TherapeuticsJennifer MichaelsonChief Scientific Officer at Cullinan Therapeutics

Also worked at Bristol Myers Squibb120

Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners

+ 114 more

Also worked at Celgene Corporation30

Courtney WallaceInvestor at Third Rock VenturesJoyce BremerInvestor at True VenturesPatrick LoerchBio Advisor at Amplify PartnersGeorge GolumbeskiPartner at Droia VenturesMichael KramarzManaging Partner at Commodore CapitalLisa WisniewskiManaging Director at Global BioAccess Fund

+ 24 more